Literature DB >> 19414402

Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma.

Christian Cordes1, Ann-Kristin Münzel, Pierre Rudolph, Markus Hoffmann, Ivo Leuschner, Stefan Gottschlich.   

Abstract

BACKGROUND: Proliferative activity has been shown to be of prognostic significance for several malignancies. Ki-67, a cell cycle associated antigen, is regarded as a promising proliferation marker. Very few results on the proliferative activity of head and neck cancer and their potential prognostic value are available.
MATERIALS AND METHODS: The proliferative activity of 104 squamous cell carcinomas of the larynx (SCCL) was analyzed retrospectively with the monoclonal antibody Ki-S11 which specifically detects the Ki-67 antigen. Median follow-up time was 47 months.
RESULTS: There was a statistically significant correlation (p<0.05) between histopathological grading, N-status and proliferative activity. There was also a significant difference for the 5-year survival between low and highly proliferating tumours. The patient group with low proliferating laryngeal cancer had a statistically (p<0.05) longer absolute and recurrence-free 5-year-survival time than patients with a highly proliferating cancer.
CONCLUSION: These results show that Ki-67 staining of SCCL with Ki-S11 is a helpful prognostic indicator for squamous cell carcinoma of the larynx with a potential clinical application.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414402

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.

Authors:  Mozaffarul Islam; Jharna Datta; James C Lang; Theodoros N Teknos
Journal:  Oral Oncol       Date:  2014-02-22       Impact factor: 5.337

2.  Increased expression of the prolactin receptor is associated with malignant laryngeal tumors.

Authors:  Luis R González-Lucano; José F Muñoz-Valle; Rafael Ascencio-Cedillo; José A Domínguez-Rosales; Gonzalo López-Rincón; Susana Del Toro-Arreola; Miriam Bueno-Topete; Adrián Daneri-Navarro; Ciro Estrada-Chávez; Ana L Pereira-Suárez
Journal:  Exp Ther Med       Date:  2012-01-30       Impact factor: 2.447

Review 3.  The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma.

Authors:  Federico Maria Gioacchini; Matteo Alicandri-Ciufelli; Giuseppe Magliulo; Corrado Rubini; Livio Presutti; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-03       Impact factor: 2.503

4.  Simultaneous Assessment of the Efficacy and Toxicity of Marine Mollusc-Derived Brominated Indoles in an In Vivo Model for Early Stage Colon Cancer.

Authors:  Babak Esmaeelian; Kirsten Benkendorff; Richard K Le Leu; Catherine A Abbott
Journal:  Integr Cancer Ther       Date:  2017-04-05       Impact factor: 3.279

5.  6-bromoisatin found in muricid mollusc extracts inhibits colon cancer cell proliferation and induces apoptosis, preventing early stage tumor formation in a colorectal cancer rodent model.

Authors:  Babak Esmaeelian; Catherine A Abbott; Richard K Le Leu; Kirsten Benkendorff
Journal:  Mar Drugs       Date:  2013-12-24       Impact factor: 5.118

6.  Histologic correlation of expression of Ki-67 in squamous cell carcinoma of the glottis according to the degree of cell differentiation.

Authors:  Rodrigo Gonzalez Bonhin; Guilherme Machado de Carvalho; Alexandre Caixeta Guimarães; Carlos Takahiro Chone; Agrício Nubiato Crespo; Albina Messias de Almeida Milani Altemani; Eliane M I Amstalden
Journal:  Braz J Otorhinolaryngol       Date:  2014-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.